• A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for a soluble glycoprotein vaccine to prevent disease caused by Nipah or Hendra viruses
• A Comparative Assessment of the Pathogenic Potential of Newly Discovered Henipaviruses
• A global-scale dataset of bat viral detection suggests that pregnancy reduces viral shedding
• A new Hendra virus genotype found in Australian flying foxes
• A potent Henipavirus cross-neutralizing antibody reveals a dynamic fusion-triggering pattern of the G-tetramer
• A recombinant Cedar virus based high-throughput screening assay for henipavirus antiviral discovery
• A Recombinant Chimeric Cedar Virus-Based Surrogate Neutralization Assay Platform for Pathogenic Henipaviruses
• A Survey of Henipavirus Tropism-Our Current Understanding from a Species/Organ and Cellular Level
• A tale of endurance: bats, viruses and immune dynamics
• A vaccine targeting antigen-presenting cells through CD40 induces protective immunity against Nipah disease
• Aggregated Hendra virus C-protein activates the NLRP3 inflammasome to induce inflammation
• An in vivo BSL-2 model for henipavirus infection based on bioluminescence imaging of recombinant Cedar virus replication in mice
• An mRNA-based reverse-vaccinology strategy to stimulate the immune response against Nipah virus in humans using fusion glycoproteins
• An Overview of Anthropogenic Actions as Drivers for Emerging and Re-Emerging Zoonotic Diseases
• Animal Models for Henipavirus Research
• Aptamer and aptasensor technology for diagnosis of infectious diseases: A mini review
• Assays for Detecting Henipavirus Antibodies
• Bat humoral immunity and its role in viral pathogenesis, transmission, and zoonosis
• Batting below Average: Failure to Manage Fatal Zoonotic Diseases
• Chimeric vaccine design against the epidemic Langya Henipavirus using immunoinformatics and validation via immune simulation approaches
• Climate Anomalies and Spillover of Bat-Borne Viral Diseases in the Asia-Pacific Region and the Arabian Peninsula
• Communication Interventions and Assessment of Drivers for Hendra Virus Vaccination Uptake
• Cooperativity mediated by rationally selected combinations of human monoclonal antibodies targeting the henipavirus receptor binding protein
• Current progress towards prevention of Nipah and Hendra disease in humans: A scoping review of vaccine and monoclonal antibody candidates being evaluated in clinical trials
• Current status of diagnostic assays for emerging zoonotic viruses: Nipah and Hendra
• Detection of Nipah and Hendra Viruses Using Recombinant Human Ephrin B2 Capture Virus in Immunoassays
• Development and laboratory evaluation of a competitive ELISA for serodiagnosis of Nipah and Hendra virus infection using recombinant Nipah glycoproteins and a monoclonal antibody
• Development and validation of an IgM antibody capture ELISA for early detection of Hendra virus
• Discovery and Evolutionary Analysis of a Novel Bat-Borne Paramyxovirus
• Discovery and genetic characterization of novel paramyxoviruses from small mammals in Hubei Province, Central China
• Discovery and Genomic Characterization of a Novel Henipavirus, Angavokely Virus, from Fruit Bats in Madagascar
• Effects of Waning Maternal Immunity on Infection Dynamics in Seasonally Breeding Wildlife
• Emerging viruses: Cross-species transmission of coronaviruses, filoviruses, henipaviruses, and rotaviruses from bats
• Enhanced broad spectrum in vitro antiviral efficacy of 3-F-4-MeO-Bn, 3-CN, and 4-CN derivatives of lipid remdesivir nucleoside monophosphate prodrugs
• Enzyme-Linked Immunosorbent Assay Using Henipavirus-Receptor EphrinB2 and Monoclonal Antibodies for Detecting Nipah and Hendra Viruses
• Establishment of a Captive Cave Nectar Bat (<em>Eonycteris spelaea</em>) Breeding Colony in Singapore
• Establishment of Intestinal Organoid from <em>Rousettus leschenaultii</em> and the Susceptibility to Bat-Associated Viruses, SARS-CoV-2 and Pteropine Orthoreovirus
• Evaluation of henipavirus chemical inactivation methods for the safe removal of samples from the high-containment PC4 laboratory
• Evaluation of the immunogenicity of an mRNA vectored Nipah virus vaccine candidate in pigs
• FeMV is a cathepsin-dependent unique morbillivirus infecting the kidneys of domestic cats
• Foals of mares vaccinated for Hendra virus have a suboptimal response to HeV vaccination
• From Protein to Pandemic: The Transdisciplinary Approach Needed to Prevent Spillover and the Next Pandemic
• Fruit bats as natural reservoir of highly pathogenic henipaviruses: balance between antiviral defense and viral toleranceInteractions between Henipaviruses and their natural host, fruit bats
• Functional Analysis of the Fusion and Attachment Glycoproteins of Mojiang Henipavirus
• Genetic diversity of bat coronaviruses and comparative genetic analysis of MERS-related coronaviruses in South Korea
• Genome Characterization of a Tailam Virus Discovered in Brown Rats in Yunnan Province, China
• Glycoprotein attachment with host cell surface receptor ephrin B2 and B3 in mediating entry of nipah and hendra virus: a computational investigation
• Habitat loss for black flying foxes and implications for Hendra virus
• Hendra Virus: An Update on Diagnosis, Vaccination, and Biosecurity Protocols for Horses
• Henipavirus Immune Evasion and Pathogenesis Mechanisms: Lessons Learnt from Natural Infection and Animal Models
• Henipavirus Matrix Protein Employs a Non-Classical Nuclear Localization Signal Binding Mechanism
• Henipavirus zoonosis: outbreaks, animal hosts and potential new emergence
• Henipavirus-induced neuropathogenesis in mice
• Henipaviruses and lyssaviruses target nucleolar treacle protein and regulate ribosomal RNA synthesis
• Henipaviruses-A constant threat to livestock and humans
• Henipaviruses: an expanding global public health concern?
• Horse populations are severely underestimated in a region at risk of Hendra virus spillover
• ILRUN Downregulates ACE2 Expression and Blocks Infection of Human Cells by SARS-CoV-2
• Indiscriminate activities of different henipavirus polymerase complex proteins allow for efficient minigenome replication in hybrid systems
• Interaction of Nipah Virus F and G with the Cellular Protein Cortactin Discovered by a Proximity Interactome Assay
• Langya henipavirus: Is it a potential cause for public health concern?
• Langya virus outbreak in China, 2022: Are we on the verge of a new pandemic?
• Livestock and Risk Group 4 Pathogens: Researching Zoonotic Threats to Public Health and Agriculture in Maximum Containment
• Measures to prevent and treat Nipah virus disease: research priorities for 2024-29
• Molecular, ecological, and behavioral drivers of the bat-virus relationship
• Multivalent viral particles elicit safe and efficient immunoprotection against Nipah Hendra and Ebola viruses
• Nano-Assembled Polyphosphazene Delivery System Enables Effective Intranasal Immunization with Nipah Virus Subunit Vaccine
• Nipah Virus
• Nipah Virus
• Nipah virus attachment glycoprotein ectodomain delivered by type 5 adenovirus vector elicits broad immune response against NiV and HeV
• Nipah Virus: A Multidimensional Update
• Nonhuman Primate Models for Nipah and Hendra Virus Countermeasure Evaluation
• Novel Hendra Virus Variant Detected by Sentinel Surveillance of Horses in Australia
• Novel variant Hendra virus genotype 2 infection in a horse in the greater Newcastle region, New South Wales, Australia
• Optimizing noninvasive sampling of a zoonotic bat virus
• Overview of Experimental Vaccines and Antiviral Therapeutics for Henipavirus Infection
• Paramyxoviruses from neotropical bats suggest a novel genus and nephrotropism
• Pathogen spillover driven by rapid changes in bat ecology
• Pathogenicity and virulence of henipaviruses
• Potent human neutralizing antibodies against Nipah virus derived from two ancestral antibody heavy chains
• Potent monoclonal antibody-mediated neutralization of a divergent Hendra virus variant
• Potential for Person-to-Person Transmission of Henipaviruses: A Systematic Review of the Literature
• Prefusion stabilization of the Hendra and Langya virus F proteins
• Preservation of scRNA-Seq Libraries Using Existing Inactivation Protocols
• Pseudotyped Virus for Henipavirus
• Rapid, sensitive, and specific, low-resource molecular detection of Hendra virus
• Recently Emerged Novel Henipa-like Viruses: Shining a Spotlight on the Shrew
• Sero-Monitoring of Horses Demonstrates the Equivac() HeV Hendra Virus Vaccine to Be Highly Effective in Inducing Neutralising Antibody Titres
• Sero-Monitoring of Horses Demonstrates the Equivac^® HeV Hendra Virus Vaccine to Be Highly Effective in Inducing Neutralising Antibody Titres
• Serological Hendra Virus Diagnostics Using an Indirect ELISA-Based DIVA Approach with Recombinant Hendra G and N Proteins
• Severe zoonotic viruses carried by different species of bats and their regional distribution
• Spatial dynamics of pathogen transmission in communally roosting species: Impacts of changing habitats on bat-virus dynamics
• Structural basis for antibody recognition of vulnerable epitopes on Nipah virus F protein
• Structural insights into the Langya virus attachment glycoprotein
• Structural Studies of Henipavirus Glycoproteins
• Structure and antigenicity of divergent Henipavirus fusion glycoproteins
• Structures of Langya Virus Fusion Protein Ectodomain in Pre- and Postfusion Conformation
• The Hendra virus vaccine: perceptions regarding the role of antibody titre testing
• Updated Insights into the Phylogenetics, Phylodynamics, and Genetic Diversity of Nipah Virus (NiV)
• Using Stochastic Modeling to Predict the Effect of Culling and Colony Dispersal of Bats on Zoonotic Viral Epidemics